Core Viewpoint - The company has made a $5 million investment in the LFM Stable Income Fund SP, which is part of the LFM Oversea Investment Fund SPC, and is now pursuing legal action to recover this investment due to difficulties in redeeming it [1][2]. Group 1 - The company’s subsidiary, Biostar Pharma, Inc., subscribed to the LFM Stable Income Fund SP with $5 million using its idle funds, with the investment expected to mature on November 29, 2025 [1]. - The company submitted a redemption request on January 21, 2025, but has not received a timely response, prompting the decision to take legal action [2]. - Legal counsel has been appointed to advance the liquidation and takeover process of the LFM Fund under Cayman Islands law [2]. Group 2 - A petition was filed in the Cayman Islands Grand Court on September 12, 2025, seeking the appointment of a liquidator for the LFM Stable Income Fund SP [2]. - The court hearing regarding the takeover application took place on November 19, 2025, with a decision expected within two weeks [2]. - The company has issued a statutory demand to LFM Oversea Investment Limited, seeking joint liability for the redemption obligations under the subscription agreement [3].
华昊中天医药-B：法律顾问已向LFM Oversea Investment Limited发出法定要求偿债书